ArticleJournal of orthopaedic case reports2021
Treatment of Femoral Neck Non-Union Using Bone Cell Therapy: A Case Report.
Article in Journal of orthopaedic case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- A 44-Year-Old Male Manual Laborer With Nonunion of a Femoral Neck Fracture Treated With Ultrasound-Guided Percutaneous Injections of Platelet-Rich Plasma: A Case Report.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionManagement of non-union and/or malunited fractures remains a challenge and achieving complete and permanent union with current standard of care is difficult. Treatments that can allow localized and accelerated three-dimensional bone formation can offer an encouraging outcome. CASE REPORT: We present a case of a middle-aged woman with femoral neck non-union, treated with a novel bone cell therapy. Fracture union was achieved within 75 days post-cell implantation. At 10-month post-cell therapy, clinical outcome in our patient was quite satisfactory and the patient is doing very well without pain or any symptoms. and reports excellent quality of life.
conclusionWe recommend the use of bone cell therapy that can provide accelerated bone healing and clinical benefits in the short-term significant long-term clinical benefits for the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.